Four studies with the same formulation [Regulatives / Guidelines]

posted by Lucas – Brazil, 2014-02-11 18:32 (4519 d 00:33 ago) – Posting: # 12403
Views: 10,547

Hi everybody

We have just finished the 4th study of Levothyroxine from the same manufacturer, on the strenghts of 25 ug, 63 ug, 100 ug and 200 ug. Only the 25ug presented a sequence effect. Someone here raised a question about the amount of tablets administered in that study, and if it may have any impact that could have caused the sequence effect. In order to use a dosage of 600 ug, 24 tablets had to be administered to the subjects. Is it possible that the high amount of tablets have caused a different response? Maybe some of the tablets did not release the drug immediatelly, causing a retard effect that affected the second period data, or something like that. Besides that, someone mentioned to me a "Memory effect", in which the human body learns how to deal with the drug, causing a different reaction at the second administration. I personally think that this is very hard to happen at only 1 single dose administration.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
351 visitors (0 registered, 351 guests [including 15 identified bots]).
Forum time: 20:06 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5